By contrast, recent studies on another class of insulin sensitizers – thiazolidinediones (TZDs) – in NAFLD showed improvement in ALT and liver histology [for review, see Ref. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.